AU Patent

AU2019283765B2 — Pyridin-2(1h)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Assigned to Forma Therapeutics Inc · Expires 2021-05-13 · 5y expired

What this patent protects

R6 R4 R5 U A R W2 W N'R Ho Ri W3 N 0 R3 (I) The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) protein with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: )I) where A, U, WI,…

USPTO Abstract

R6 R4 R5 U A R W2 W N'R Ho Ri W3 N 0 R3 (I) The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) protein with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: )I) where A, U, WI, W2, W3, R1-R6, and R9 are described herein.

Drugs covered by this patent

Patent Metadata

Patent number
AU2019283765B2
Jurisdiction
AU
Classification
—
Expires
2021-05-13
Drug substance claim
No
Drug product claim
No
Assignee
Forma Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.